MedPath

To Evaluate and study analgesic effect of fentanyl as an additive to intrathecal hyperbaric ropivacaine for lower limb surgery

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2023/05/052455
Lead Sponsor
Dr. Sarvjeet Kaur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients scheduled for elective lower limb surgeries under spinal anaesthesia.

2.Patients aged between 18-60 years of either gender, giving valid informed and written consent.

3.Patients belonging to American Society of Anaesthesiology (ASA) grade I and II.

Exclusion Criteria

1.Patient with Known allergy to drugs used in study

2.Any contraindications to spinal anaesthesia

3.Coagulopathy and bleeding diathesis

4.Patients diagnosed with psychiatric ailments

5.History of drug/substance abuse

6.Patients on anti arrhythmic treatment

BMI >35 kg/m2

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To study duration of analgesia with intrathecal ropivacaine in lower limb surgery. <br/ ><br>2.To study duration of analgesia with intrathecal ropivacaine and fentanyl in lower limb surgery. <br/ ><br>3.To compare duration of analgesia with intrathecal ropivacaine versus intrathecal ropivacaine with fentanyl in lower limb surgery. <br/ ><br>Timepoint: Outcome will be assessed at the end of study that is 12 months
Secondary Outcome Measures
NameTimeMethod
ATimepoint: NA
© Copyright 2025. All Rights Reserved by MedPath